KillBait is a news aggregator developed by students and professionals in journalism and web development. Our focus is on providing readers with clear, concise, and relevant summaries of each news story. Our main innovation is a system powered by Artificial Intelligence (AI) designed to detect clickbait or sensationalist news. Instead of simply discarding these articles, our system generates more accurate summaries, free from exaggeration and deception, ensuring readers won't be disappointed.
Elder Millennial. Husband. Father of 4. Dog owner. IT Professional. Tech enthusiast. CSS tinkerer. Music lover. Huge Sleep Token and Bilmuri fan. Non-practicing white person. Grew up in MD. Lived in and around Baltimore for a long time. Currently living in VA with my wife, 3 youngest daughters, and our 2 dogs. https://jcrabapple.com Admin of: https://DMV.Community (Mastodon)
💊 A viral video calls benfotiamine (fat-soluble vitamin B1) a "revolutionary" anti-inflammatory breakthrough. The real story is more complicated.
The video references a real June 2026 study where researchers used computational drug repurposing to identify benfotiamine as a P2Y14R antagonist. P2Y14R is a genuine inflammatory target. The study tested it in mice with colitis and gouty arthritis and reported positive results.
But here's what the video leaves out:
The study is preclinical (mice + computer models), with 0 citations. "Revolutionary" is a stretch.
Multiple human RCTs found NO anti-inflammatory effect. A 24-month trial (300mg/day) in Type 1 diabetics showed no change in inflammatory markers. A 12-week trial (900mg/day) in diabetic nephropathy found no effect on inflammation. The BOND study (12 months, 600mg/day) found no effect on neuropathy outcomes.
The creator, Dr. Rick Pescatore, founded BellyMD, a supplement company selling benfotiamine products. This financial relationship is not disclosed in the video.
Benfotiamine is real, safe, and inexpensive. The preclinical anti-inflammatory science is genuine. But human trials have not confirmed the anti-inflammatory claims, and the "breakthrough" framing serves a product the creator sells.
Read more: https://pmc.ncbi.nlm.nih.gov/articles/PMC3329837/ https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0040427 https://doi.org/10.1136/bmjdrc-2025-005773
Opinion and editorials from The New York Times. See old posts. I am a bot that mirrors an RSS feed. Source: https://rss.nytimes.com/services/xml/rss/nyt/Opinion.xml
Tips, tricks, and downloads for getting things done. See old posts. I am a bot that mirrors an RSS feed. Source: https://lifehacker.com/feed/
The New York Times Home Page news feed. See old posts. I am a bot that mirrors an RSS feed. Source: https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml
A lifestyle magazine for the Hudson Valley and Catskills. See old posts. I am a bot that mirrors an RSS feed. Source: https://www.chronogram.com/feed/
Migrated from @bicmay@med-mastodon.com | She/her | FM physician interested in helping patients get all the health care they need and none they don't | Boosts ≠ endorsements | Opinions are mine, not of any organization I'm affiliated with Posts autodelete after 2 weeks Header: Sunlight pouring through clouds above landscape of mountains and volcanic crater Profile: Man with black hair wearing black top, left dangling earring, and bracelets looking at camera.
You've seen all posts